Clinical Supplies Management Acquires Another European Company

Clinical Supplies Management pic

Clinical Supplies Management
Image: csmondemand.com

Based in Greenwich, Connecticut, private equity firm Great Point Partners invests in health care companies. One of Great Point Partners’ portfolio firms, Clinical Supplies Management (CSM), acquired B&C Group (B&C), headquartered in Brussels, Belgium, in January 2017.

CSM handles the clinical supply chain of hundreds of pharmaceutical and biotechnology firms around the world, helping clinical trials to be on budget and on time. Its full array of services to comply with Current Good Manufacturing Practice regulations include packaging and labeling, storage, global distribution, and clinical supplies consulting. The acquisition will enable CSM to leverage B&C’s expertise in clinical trial supplies provisioning and biomedical services across the CSM global network.

CSM now has two full-service facilities in Europe, including its December 2016 acquisition of Frankfurt, Germany-based, Theorem Clinical Supply. These complementary acquisitions expand the firm’s biomedical sample services and disaster recovery backup capabilities in Europe. A European expansion is one of Great Point Partner’s central strategies for CSM, which also will assist in better serving CSM pharmaceutical clients performing joint clinical trails in the United States and Europe.

Clinical Supplies Management’s Second European Acquisition

Clinical Supplies Management pic

Clinical Supplies Management
Image: csmondemand.com

A Connecticut-based investment firm that focuses primarily on the health care industry, Great Point Partners (GPP) has invested its clients capital since its formation in 2003. Clinical Supplies Management (CSM), one of Great Point Partners’ portfolio companies, announced its acquisition of a second European company in January 2017.

Following its purchase of Theorem Clinical Supply, which is a Frankfurt-based health care business, CSM has acquired B&C Group. Headquartered in Brussels, Belgium, B&C provides clinical trial supplies, in addition to biomedical sample services.

Both acquisitions have expanded CSM’s European footprint, offering it two full-time facilities on the continent. Further, CSM’s biomedical sample services have expanded due to the acquisitions.

As part of the most recent acquisition, B&C’s CEO Phillipe Van der Hofstadt will lead CSM’s European activities going forward. In speaking about the opportunity, Van der Hofstadt noted that the acquisition of B&C formalized a longstanding partnership between it and CSM, adding that CSM is now perfectly poised to offer greater value to its customers.